Takashi Dejima
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL).
Journal: Lower urinary tract symptoms
Published: February 07, 2024
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia.
Journal: Lower urinary tract symptoms
Published: December 05, 2021
GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trial.
Journal: Lower urinary tract symptoms
Published: March 10, 2020
Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.
Journal: Cancer science
Published: April 06, 2018
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
Journal: EMBO molecular medicine
Published: January 20, 2018
The Association of Polymorphisms in the Gene Encoding Gonadotropin-Releasing Hormone with Serum Testosterone Level during Androgen Deprivation Therapy and Prognosis of Metastatic Prostate Cancer.
Journal: The Journal of urology
Published: September 11, 2017
Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer.
Journal: Endocrine-related cancer
Published: February 07, 2017
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
Journal: The Prostate
Published: September 20, 2016
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor.
Journal: The Journal of urology
Published: August 01, 2016
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.
Journal: Annals of surgical oncology
Published: July 24, 2016
Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
Journal: International immunopharmacology
Published: December 14, 2015
Last Updated: 09/26/2026